Clinical Trial Update: Calcium-Phosphorus Regulation Therapy on Heart Valve Disease [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial in China is recruiting to evaluate a Calcium-Phosphorus Regulation Therapy for degenerative heart valve disease and related conditions,…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Calcium-phosphorus Metabolism Disorders
• Chronic Kidney Disease
• Degenerative Heart Valve Disease
• Heart Valve Calcification

Snippet

Sponsor: China National Center for Cardiovascular Diseases | Conditions: Degenerative Heart Valve Disease, Heart Valve Calcification | Phase 4 | Status: RECRUITING